INICIO

Continuation of the Revista Mexicana de Cardiología

    
  • Home
  • Instructions for authors
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

Diagnostic and therapeutic phenotypes in patients with high blood pressure

Galván-Oseguera, Héctor; Moreno-González, Agustina

ABSTRACT

In patients with high blood pressure (HBP), we can find different characteristics which can help us establish the diagnosis, prognosis, and treatment. With the advancement of technology and knowledge of the pathophysiology of HBP, we now have other diagnostic methods outside the office which allow us to measure BP in different circumstances. Within HBP individual patients may have disease attributes that, alone or in combination, describe different phenotypes between individuals in relation to parameters which have clinical significance. Some of the main characteristics that we identify are those related to BP measurement, to the origin of BP elevation, to the circumstance in which BP was taken, to patients with high BP variability, patients who do not respond to treatment, patients where elevation of their BP is an emergency and one of the most important according to cardiovascular risk. From these characteristics we were able to identify 29 different HBP phenotypes in the literature, which can help us better define diagnosis, prognosis, and treatment. Many authors and clinicians call it a "tailor-made suit"; however, we will call it the hypertensive phenotype.
  FULL TEXT PDF  

Keywords

High blood pressure clinical phenotypes cardiovascular outcomes




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Implementation and barriers of high blood pressure guidelines and standards
    2022, Vol.33, Núm. S3
  • Understanding high blood pressure: pathophysiological advances
    2022, Vol.33, Núm. S3
  • The detection and study of patient with high blood pressure
    2022, Vol.33, Núm. S3
  • Diagnostic and therapeutic phenotypes in patients with high blood pressure
    2022, Vol.33, Núm. S3
  • High blood pressure and telemedicine: past, present and future
    2022, Vol.33, Núm. S3
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2


Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: EN TRÁMITE. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 4 de abril de 2022.

 

2022     |     https://www.cardiovascularandmetabolicscience.org.mx/